Corbus Pharmaceuticals Holdings, Inc.
CRBP
$10.67
$0.393.79%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 103.98M | 116.59M | 132.79M | 149.06M | 159.36M |
| Total Receivables | -- | 1.50M | 1.10M | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.30M | 4.45M | 3.19M | 3.63M | 1.24M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 285.00K | 285.00K | 285.00K | 285.00K | 285.00K |
| Total Current Assets | 107.57M | 122.83M | 137.36M | 152.98M | 160.89M |
|
|
|||||
| Total Current Assets | 107.57M | 122.83M | 137.36M | 152.98M | 160.89M |
| Net Property, Plant & Equipment | 1.56M | 1.88M | 2.19M | 2.52M | 2.90M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 385.00K | 385.00K | 385.00K | 385.00K | 385.00K |
| Total Assets | 109.51M | 125.09M | 139.93M | 155.88M | 164.17M |
|
|
|||||
| Total Accounts Payable | 2.74M | 3.99M | 4.07M | 4.79M | 2.89M |
| Total Accrued Expenses | 12.58M | 7.65M | 5.90M | 5.43M | 7.18M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.74M | 1.70M | 1.65M | 1.61M | 1.56M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 17.06M | 13.33M | 11.62M | 11.82M | 11.63M |
|
|
|||||
| Total Current Liabilities | 17.06M | 13.33M | 11.62M | 11.82M | 11.63M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 307.00K | 761.00K | 1.21M | 1.63M | 2.05M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 17.37M | 14.09M | 12.83M | 13.45M | 13.67M |
|
|
|||||
| Common Stock & APIC | 627.03M | 622.56M | 621.00M | 619.29M | 617.65M |
| Retained Earnings | -534.88M | -511.53M | -493.87M | -476.89M | -467.36M |
| Treasury Stock & Other | -3.00K | -39.00K | -23.00K | 35.00K | 207.00K |
| Total Common Equity | 92.15M | 110.99M | 127.11M | 142.43M | 150.50M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 92.15M | 110.99M | 127.11M | 142.43M | 150.50M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 92.15M | 110.99M | 127.11M | 142.43M | 150.50M |
|
|
|||||